As of March 31, 2026, Wai Yuen Tong Medicine Holdings Limited carries a market capitalization of 367.75M, placing it among publicly traded companies globally. Its enterprise value stands at 557.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 367.75M |
| Enterprise Value | 557.04M |
As of March 31, 2026, Wai Yuen Tong Medicine Holdings Limited has 1.11B shares outstanding.
| Shares Outstanding | 1.11B |
These figures are as of March 31, 2026.
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.31 |
As of March 31, 2026, Wai Yuen Tong Medicine Holdings Limited maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.40 |
| Quick Ratio | 0.34 |
| Debt / Equity | 28.63 |
These figures cover the twelve months ended March 31, 2026.
| Employee Count | 725.00 |
As of the close on November 17, 2026, Wai Yuen Tong Medicine Holdings Limited's stock has declined approximately 18.89% over the past 52 weeks. The 50-day moving average sits at 0.35, while the 200-day moving average is 0.35.
| 52-Week Price Change | -18.89% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.35 |
As of March 31, 2026, Wai Yuen Tong Medicine Holdings Limited holds 147.44M in cash and equivalents against 337.95M in total debt, resulting in a net debt position of 146.01M. Total book value stands at 1.18B, with working capital of 170.12M providing operational flexibility.
| Cash & Cash Equivalents | 147.44M |
| Total Debt | 337.95M |
| Net Debt | 146.01M |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 1.06 |
| Working Capital | 170.12M |
Wai Yuen Tong Medicine Holdings Limited's most recent stock split took place on August 31, 2016 with a 179:200 split ratio.
| Last Split Date | 8/31/2016 |
| Split Ratio | 179:200 |
Already premium?